Cipla acquires US-based Avenue Therapeutics for $215 million News News / News 5 years ago 458 Views comments The acquisition will give Cipla access to specialty drug Tramadol delivered intravenously (IV) to manage post-operative pain. Read more
News EXPOSED: A bogus co with 2000 bank a/cs transacted Rs 4,000 cr in cash during cash ban News / News - 6 years ago
Comments